Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain by Vioque, Jesus et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Cancer
Open Access Research article
Esophageal cancer risk by type of alcohol drinking and smoking: a 
case-control study in Spain
Jesus Vioque*1,2, Xavier Barber3, Francisco Bolumar2,4, Miquel Porta2,5, 
Miguel Santibáñez1, Manuela García de la Hera1,2, Eduardo Moreno-Osset6 
for the PANESOES Study Group
Address: 1Departamento Salud Pública, Universidad Miguel Hernández, Elche-Alicante, Spain, 2CIBER de Epidemiología y Salud Pública, 
CIBERESP, Spain, 3Departamento de Estadística, Centro de Investigación Operativa, Universidad Miguel Hernández de Elche-Alicante, Spain, 
4Facultad de Medicina, Universidad de Alcalá, Madrid, Spain, 5Institut Municipal d'Investigació Mèdica, Universitat Autònoma de Barcelona, Spain 
and 6Servicio de Medicina Digestiva, Hospital Universitario Dr. Peset, Universidad de Valencia, Valencia, Spain
Email: Jesus Vioque* - vioque@umh.es; Xavier Barber - xbarber@umh.es; Francisco Bolumar - francisco.bolumar@uah.es; 
Miquel Porta - mporta@imim.es; Miguel Santibáñez - santibanyez_mig@gva.es; Manuela García de la Hera - manoli@umh.es; 
Eduardo Moreno-Osset - eduardo.moreno@uv.es; the PANESOES Study Group - vioque@umh.es
* Corresponding author    
Abstract
Background: The effect of tobacco smoking and alcohol drinking on esophageal cancer (EC) has never been explored
in Spain where black tobacco and wine consumptions are quite prevalent. We estimated the independent effect of
different alcoholic beverages and type of tobacco smoking on the risk of EC and its main histological cell type (squamous
cell carcinoma) in a hospital-based case-control study in a Mediterranean area of Spain.
Methods: We only included incident cases with histologically confirmed EC (n = 202). Controls were frequency-
matched to cases by age, sex and province (n = 455). Information on risk factors was elicited by trained interviewers
using structured questionnaires. Multiple logistic regression was used to estimate adjusted odds ratios and 95%
confidence intervals (CI).
Results: Alcohol drinking and tobacco smoking were strong and independent risk factors for esophageal cancer. Alcohol
was a potent risk factor with a clear dose-response relationship, particularly for esophageal squamous-cell cancer.
Compared to never-drinkers, the risk for heaviest drinkers (≥ 75 g/day of pure ethanol) was 7.65 (95%CI, 3.16–18.49);
and compared with never-smokers, the risk for heaviest smokers (≥ 30 cigarettes/day) was 5.07 (95%CI, 2.06–12.47). A
low consumption of only wine and/or beer (1–24 g/d) did not increase the risk whereas a strong positive trend was
observed for all types of alcoholic beverages that included any combination of hard liquors with beer and/or wine (p-
trend<0.00001). A significant increase in EC risk was only observed for black-tobacco smoking (2.5-fold increase), not
for blond tobacco. The effects for alcohol drinking were much stronger when the analysis was limited to the esophageal
squamous cell carcinoma (n = 160), whereas a lack of effect for adenocarcinoma was evidenced. Smoking cessation
showed a beneficial effect within ten years whereas drinking cessation did not.
Conclusion: Our study shows that the risk of EC, and particularly the squamous cell type, is strongly associated with
alcohol drinking. The consumption of any combination of hard liquors seems to be harmful whereas a low consumption
of only wine may not. This may relates to the presence of certain antioxidant compounds found in wine but practically
lacking in liquors. Tobacco smoking is also a clear risk factor, black more than blond.
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Background
Most epidemiological studies have identified tobacco
smoking and alcohol drinking as the main risk factors for
esophageal squamous-cell carcinoma or unspecified
esophageal cancer [1-3], usually with a monotonic and
strong dose-response relationship [4]. The evidence that
high alcohol consumption increases the risk of cancer of
the esophagus is quite convincing at present; most of it
suggests that it is the amount of alcohol consumed, rather
than the particular drink that determines the risk. How-
ever, a prospective cohort study in Denmark observed that
low wine consumption, compared to beer and hard liq-
uor, did not increase risk [5]. Two population-based case-
control studies also presented data supporting this obser-
vation [6,7]. In an ecological study in Spain, trends of per
capita consumption of beer, spirits, and total alcohol con-
sumption were positively correlated with oesophageal
cancer mortality in men whereas wine consumption
showed no relationship with oesophageal cancer mortal-
ity either in men or women[8]. As the consumption of all
types of alcoholic drinks is quite prevalent in Spain, it is
relevant to assess the risk of esophageal cancer in relation
to them.
Tobacco smoking has also a clear role in the aetiology of
esophageal cancer [1,2]. Despite the high prevalence of
consumption, particularly of black tobacco, an associa-
tion between the type of tobacco smoking and esophageal
cancer has never been explored by epidemiological stud-
ies in Spain, only in South America or France[4,9].
In addition to smoking and alcohol, other factors such as
a low socioeconomic status, an infrequent consumption
of fruits and vegetables and, in some areas of Asia, the
betel nut chewing, have also been related to esophageal
cancer [10-13]; these factors account for a high proportion
of cases, particularly for the esophageal squamous cell
type, the most frequent histological type [11,12,14].
We conducted a case-control study in Valencia and Ali-
cante, Spain, to estimate the independent effects of differ-
ent alcoholic beverages (beer, wine and spirits) and type
of tobacco smoking (black and blond) on the risk of
esophageal cancer and its main histological cell type
(squamous cell carcinoma).
Methods
Design
This research was part of the PANESOES project, a pro-
spective hospital-based case-control study designed to
explore the influence of major lifestyles and diet on the
risk of three gastrointestinal cancers, pancreas, oesopha-
gus and stomach. The PANESOES Study aimed to recruit
approximately 200 cases for oesophagus, 200 for pancreas
cancer, 400 cases for stomach cancer, and 400–450 con-
trols. This sample size was planned to estimate as statisti-
cally significant (p < 0.05) a RR over 1.5 for stomach
cancer and high prevalent exposures such as tobacco
smoking and alcohol drinking, and a RR over 1.8 for
oesophagus and pancreas cancer.
Eligible subjects were Spanish-speaking men and women
30–80 years old, and hospitalized between January 1995
and March 1999 in any of nine participant hospitals in the
provinces of Alicante and Valencia. These nine hospitals
are among the ten main hospitals from the Health Care
Service in Valencia and Alicante that were invited to par-
ticipate (only one hospital in Valencia declined participa-
tion). The access to the Health Care System in Spain is free
and universal; thus, our case series may be considered rep-
resentative as the participant hospitals accounted for
approximately 90% of cases in both provinces.
All subjects were informed of the study objectives and
gave their informed consent before the interview.
Research protocols were approved by the local ethics and/
or research committees of the participating Hospitals and
the University.
Subjects
Cases were patients newly diagnosed with a primary inva-
sive cancer of the oesophagus. Pathology reports were
obtained for all case patients initially diagnosed as
esophageal cancer, and final inclusion in the case series
was based on histological confirmation. A total of 211
cases were initially identified as eligible for participation;
two cases refused interview (0.9%), and seven cases were
not finally confirmed (3.3%). The final analysis was thus
based on 202 cases. The pathological diagnosis was con-
firmed as squamous cell carcinoma in 160 cases (79.2%)
and adenocarcinoma in 42 cases (20.8%).
Control subjects were selected from the same hospitals
from which cases were identified and during the same
period. Controls were frequency matched to the expected
distribution of case subjects of the whole PANESOES
study (i.e. cases of oesophagus, stomach and pancreas,
and controls) by three age groups (<60 years, 60–69 and
70–80 years), sex, and province (Alicante and Valencia). A
wide inclusion criterion was used to select controls from
diseases not related a priori to the main exposures of inter-
est (tobacco, alcohol and diet). The overall participation
rate of the 457 eligible controls was 99.6%, leaving 455
controls subjects with completed interviews. The distribu-
tion of the main diagnoses for the control group was, in
decreasing order: hernia (34.0%), degenerative osteoar-
thritis/arthritis (21.3%), fractures/injuries/orthopaedic
processes (18.9%), appendicitis (6.4%) and other, less
prevalent, conditions (19.3%).BMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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Exposure data
Face-to-face interviews were conducted in-hospital for all
participants by trained interviewers, using a structured
questionnaire. Interviews were administered directly to
the study subjects, rather than to the next of kin, for
89.2% of the target case subjects and for 96% of the target
control subjects. The average time required to complete
the questionnaire was 40 minutes. While interviewers
could not be blinded to the case/control status, they were
unaware of the main study hypothesis and were trained to
administer strictly the structured questionnaires in an
equal manner to case and controls.
Information was collected on demographic characteris-
tics, tobacco and alcohol use, medical history and other
lifestyle factors. The interview elicited details on usual
tobacco use, including the product/tobacco type (black or
blond cigarettes, cigars, pipes) as well as intensity of use,
the age at which the habit started and stopped, the total
duration of use excluding the years stopped, the years
since last use for each type of product, and the level of
inhalation when smoking (partially or totally). A never
smoker was defined as someone having smoked fewer
than 100 cigarettes ever or less than one cigarette per day
for one year. A former smoker was defined as someone
having stopped smoking 1 or more years before the inter-
view. We computed the average number of cigarettes
smoked per day including type of tobacco smoked, life-
time number of cigarettes smoked and pack-years of
smoking (number of 20-cigarette packs per day multiplied
by number of years smoking). Only 2 cases and 8 controls
simultaneously smoked both blond and black tobacco,
and they were considered as mainly blond tobacco smok-
ers.
Alcohol consumption patterns were assessed through
inquiries into the usual intake for each type of beverage
separately, i.e. beer, wine, or liquor. Since the intake of
only wine and/or beer intake was uncommon among
cases, these two alcoholic beverages were combined in the
analysis. Since only 8 participants consumed liquors but
not beer or wine, we estimated a category for the com-
bined consumption of liquors with any combination of
beer and/or wine (All types of beverages). The average rel-
ative contributions of beer, wine and liquor consumption
in this category were 30%, 50% and 20% respectively. The
three types of alcohol were also combined to give an over-
all estimate of the alcohol consumption. A never drinker
was defined as having consumed less than one drink per
month. One drink was defined as 200 cc of beer, 125 cc of
wine, or 50 cc of hard liquor. The content of pure alcohol
was calculated according to the following concentrations
specific for Spain: 5% for beer; 12 percent for wine; and 40
percent for hard liquors. The resulting values were con-
verted to grams multiplying 1 ml of pure ethanol per 789
mg [15]. The average in grams of pure ethanol consumed
per day, type of alcoholic beverage, and life time duration
of the habit, the age at starting and stopping the habit, and
then the years since quitting drinking were also estimated.
A former drinker was defined as having stopped drinking
1 or more years before the interview.
The fruit and vegetable intake was assessed by a food fre-
quency questionnaire (FFQ). For this study, we adapted
and validated a FFQ of 93 food items similar to the Har-
vard questionnaire in order to assess the diet five years
before the interview in the hospital [16-18]. Participants
were asked to report their average consumption of 12 veg-
etables and 10 fruit items. The average daily intakes for
each fruit and vegetable were summed to compute the
total fruit and vegetable intake in grams, and they were
adjusted for energy intake using the residual method [19].
We further computed tertiles of energy-adjusted intake of
fruit and vegetable using the distribution of cases and con-
trols in the whole PANESOES study (cases of oesophagus,
stomach and pancreas, and controls).
Statistical Analysis
We used unconditional logistic regression to estimate
odds ratios (OR), as an estimate of relative risk, and corre-
sponding 95% confidence intervals (CIs) [20]. All regres-
sion models included as covariates the three frequency-
matched factors, sex (men/women), age (<60 years, 60–
69 years, 70–80 years) and hospital origin (Valencia/Ali-
cante) entered as indicator variables; the educational level
(<primary, primary completed, and ≥ secondary school
entered as indicator variable); and the different variables
of alcohol intake and tobacco smoking also using indica-
tor variables. In addition, we adjusted for a potential con-
founding effect of fruit and vegetable intake (in tertiles
and entered as indicator variables), and energy intake.
Tests for trend in the ORs across exposure strata were cal-
culated for ordinal variables by using logistic models that
included categorical terms as continuous variables in a
model with all the potential confounders and, where
appropriate, omitting the never or former users/exposed.
For trend-tests, we used the likelihood ratio test statistic
with one degree of freedom. Although the study sample
size did not allow us to estimate tests of interactions, we
performed exploratory analyses for the effects of alcohol
and tobacco by strata of never-ever smoking status and
never-ever drinking status, respectively. All analyses were
performed with STATA-8 [21]. Statistical significance was
set at 0.05. All reported P values are from two-sided tests.
Results
Table 1 shows the distribution of cases and controls
according to demographic characteristics and main expo-
sure variables. The distribution of the frequency-matchedBMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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variables age, sex and province were comparable between
the control series and the overall case series of the PANE-
SOES study (i.e., cancers of oesophagus, stomach and
pancreas, data not shown). The educational level was
comparable between cases and controls. Alcohol intake,
tobacco smoking and a low intake of fruit and vegetable
were more prevalent among cases than controls.
Table 2 shows risk estimates according to various patterns
of alcohol intake. We identified moderate to strong effects
for all measures of amount and duration (years of alcohol
drinking); risk was particularly strong for all types of bev-
erages. Former drinkers and current drinkers experienced,
respectively, a 4.3 and 2.1-fold increase of risk over never
drinkers. An increasing risk of esophageal cancer was
observed according to the daily amount of pure ethanol
consumption (p-trend < 0.00001); risk was very high and
significant among subjects consuming ≥ 75 g/d (OR =
7.65). Concerning the beverage type, drinkers of all types
of beverages showed the highest risk (OR = 4.39) and ever
drinkers of only beer also showed a significant effect
(3.07); however, no significant effects were observed for
drinkers of only wine or wine and/or beer. When the daily
amount by type of beverage was considered, no signifi-
cantly increased risks were observed for wine-beer com-
bined consumption. For all types of alcoholic beverages
combined, a non-significant risk was observed for a daily
consumption of 1–24 g/day (OR = 1.53), whereas risk
increased sharply to 3.9 and 10.6-fold for the upper cate-
gories (p-trend<0.0001).
Regarding duration of drinking, statistically significant
increased risks were observed for up to 40 years of drink-
ing, after which no significant increase was observed
(Table 2). Age at start drinking was not significantly asso-
ciated to a higher risk of esophageal cancer. Drinking ces-
sation in the last 5 years was associated with a strong risk
excess compared with persistent drinkers (OR = 3.60, 95%
CI 1.34–9.69); the risk decreased thereafter although still
remained higher than in current drinkers.
Table 2 also shows the estimated ORs according to various
patterns of alcohol intake specifically for the esophageal
squamous-cell carcinoma histological type (n = 160
cases). Most effects were approximately 3 times higher
than risk estimates for the whole case series (n = 202
Table 1: Distribution of socio-demographic characteristics and other exposure variables among case and control subjects
Variables Casesa % Controls %
Sex
Men 187 92.61 285 62.64
Women 15 7.39 170 27.78
Age
<60 years old 86 42.36 149 32.75
60–69 years old 79 39.41 167 36.70
≥ 70 years old 37 18.23 139 30.55
Province
Alicante 45 22.66 139 30.55
Valencia 157 77.34 316 69.45
Educational level
<Primary 114 56.65 246 54.07
Primary 67 33.00 172 37.80
≥ Secondary 21 10.34 37 8.13
Alcohol intake
Never 16 7.88 171 37.36
Ever 186 92.12 284 62.64
Tobacco smoking
Never smoker 23 11.39 218 47.91
Ever smoker 179 88.61 237 52.09
Fruit and Vegetable daily intake (in tertile)
< 166 g/d 121 59.90 104 22.86
166–255 g/d 43 21.29 141 30.99
>255 g/d 38 18.81 210 46.15
a All cases were histologically confirmed.BMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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cases). The effects of all types of alcoholic beverages, were
in general 2 to 4-fold higher than those observed for
drinkers of only wine and/or beer. The highest risk of
esophageal cancer was observed among cases with an
average daily intake of pure ethanol ≥ 75 g/d (OR = 23.20,
95% CI: 7.19–74.90), and particularly for those consum-
ing ≥ 75 g/d of all types of alcoholic beverages (OR =
35.03, 95% CI: 10.28–119.31). No significant effects were
observed for only wine or beer drinkers 1–24 g/d.
Table 3 shows adjusted risk estimates according to various
patterns of tobacco smoking. The risk of esophageal can-
cer was more than doubled among ever smokers. Current
smokers presented a 2.6-fold increase of risk with respect
Table 2: Adjusteda odds ratios (OR) for esophageal cancer, and esophageal squamous-cell carcinoma, according to alcohol 
consumption
No. of controls All esophageal cancer cases Esophageal squamous-cell carcinoma cases
Cases ORa 95% CI Cases ORa 95% CI
Alcohol Drinking Status
Never< 171 16 1.00 6 1.00
Ever 284 186 2.41 (1.24 – 4.71) 154 5.34 (2.05 – 13.91)
Never 171 16 1.00 6 1.00
Former drinker 49 38 4.28 (1.92 – 9.56) 31 11.03 (3.73 – 32.62)
Current drinker 235 148 2.06 (1.04 – 4.08) 123 4.48 (1.69 – 11.83)
Average of pure ethanol (g/day)
Never 171 16 1.00 6 1.00
Former drinker 49 38 5.40 (2.43 – 12.00) 31 16.03 (5.34 – 48.07)
1–24 g/d 147 27 1.16 (0.54 – 2.49) 12 1.71 (0.56 – 5.20)
25–74 g/d 62 45 2.89 (1.29 – 6.48) 38 8.02 (2.64 – 24.40)
≥ 75 g/d 26 75 7.65 (3.16 – 18.49) 72 23.20 (7.19 – 74.90)
p-value for linear trend <0.00001 <0.00001
Type of drink (g/day)
Never 171 16 1.00 6 1.00
Only wine 65 12 1.20 (0.49 – 2.91) 7 1.92 (0.56 – 6.64)
Only beer 26 8 3.07 (1.06 – 8.90) 6 7.98 (2.13 – 29.92)
Only wine and/or beer 67 15 1.44 (0.59 – 3.47) 9 2.49 (0.73 – 88.46)
All types of beverages 126 151 4.39 (2.08 – 9.22) 132 12.15 (4.17 – 34.56)
Never 171 16 1.00 6 1.00
Former drinker 49 38 5.50 (2.47 – 12.27) 31 16.74 (5.53 – 50.67)
Wine and/or Beer 1–24 g/d 107 14 1.04 (0.45 – 2.41) 6 1.48 (0.43 – 5.05)
Wine and/or Beer ≥ 25 g/d 30 13 2.04 (0.76 – 5.46) 11 5.48 (1.52 – 19.71)
All types 1–24 g/d 40 13 1.53 (0.58 – 4.01) 6 2.47 (0.62 – 9.86)
All types ≥ 25 g/d 58 108 5.76 (2.59 – 12.83) 100 17.22 (5.68 – 52.21)
All types 25–74 g/d 40 39 3.88 (1.64 – 9.15) 32 10.47 (3.26 – 33.64)
All types ≥ 75 g/d 18 69 10.62 (4.14 – 27.24) 68 35.03 (10.28 – 119.31)
p-value for linear trend <0.0001 <0.0001
Years of alcohol drinking
0 171 16 1.00 6 1.00
1–19 16 15 4.06 (1.37 – 12.00) 11 8.21 (2.08 – 32.32)
20–39 121 92 2.96 (1.42 – 6.14) 76 6.28 (2.27 – 17.35)
≥ 40 129 71 1.71 (0.80 – 3.61) 62 3.99 (1.41 – 11.24)
p-value for linear trend 0.316 0.036
Age at starting
<18 yr 51 43 1.00 39 1.00
18–20 yr 88 50 1.94 (0.88 – 4.27) 40 0.63 (0.29 – 1.37)
21–29 yr 59 34 1.04 (0.53 – 2.02) 31 0.83 (0.34 – 2.02)
≥ 30 yr 72 52 1.71 (0.86 – 3.40) 40 0.91 (0.36 – 2.29)
Years since quitting
Current Drinker 235 148 1.00 123 1.00
<5 yr 12 16 3.60 (1.34 – 9.69) 14 5.89 (2.01 – 17.25)
≥ 5 yr 37 22 1.71 (0.86 – 3.41) 17 1.70 (0.79 – 3.66)
a Adjusted for sex, age, educational level, province and tobacco smoking (never, past, <20, 20–49 and ≥ 50 pack-years), the energy-adjusted intake 
of fruit and vegetable in tertiles, and energy intake.BMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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to never smokers. The adjusted ORs increased with the
number of cigarettes smoked per day up to 5 among cases
smoking ≥ 30 cigarettes/day (p-trend = 0.002), and with
increasing years of smoking (p-trend = 0.030). Pack-years
also showed a significant dose-response (p-trend =
0.005). No association was found with age at which sub-
jects started smoking. After smoking cessation there was a
reduction of risk of 35% for ten or more years and 45% for
less than ten years that overall was statistically significant
(LRS, p-value = 0.042). A statistically significant increased
risk was observed for black tobacco but not for blond
tobacco. Smokers who totally inhaled the tobacco experi-
enced a statistically significant higher risk than non- or
partially inhaling smokers. The risks for esophageal squa-
mous-cell carcinoma were very similar to those observed
for the whole case series.
Table 3: Adjusteda odds ratios (OR) for esophageal cancer, and esophageal squamous-cell carcinoma, according to tobacco smoking
No. of controls All esophageal cancer cases Esophageal squamous-cell carcinoma cases
Cases ORa 95% CI Cases ORa 95% CI
Smoking Status
Never 218 23 1.00 15 1.00
Ever 237 179 2.12 (1.06 – 4.23) 145 1.70 (0.72 – 4.03)
Never 218 23 1.00 15 1.00
Former-Smoker 117 55 1.61 (0.76 – 3.40) 39 1.08 (0.43 – 2.73)
Current Smoker 120 124 2.58 (1.26 – 5.28) 106 2.28 (0.95 – 5.51)
Average No. of cigarettes/day
Never 218 23 1.00 15 1.00
Former smoker 117 55 1.68 (0.79 – 3.57) 39 1.16 (0.45 – 2.99)
<15 27 11 1.70 (0.63 – 4.58) 8 1.35 (0.41 – 4.48)
15–29 58 58 2.45 (1.11 – 5.44) 47 2.05 (0.78 – 5.42)
≥ 30 23 51 5.07 (2.06 – 12.47) 48 5.82 (1.96 – 17.23)
Pipe/Cigars 12 4 1.58 (0.41 – 6.21) 3 1.49 (0.30 – 7.46)
p-value for linear trend 0.002 0.006
Years of cigarette smoking
Never 218 23 1.00 15 1.00
<20 39 14 1.78 (0.69 – 4.59) 4 0.54 (0.12 – 2.11)
20–29 48 32 1.94 (0.81 – 4.63) 26 1.62 (0.57 – 4.65)
≥ 30 150 134 2.25 (1.10 – 4.58) 115 2.03 (0.84 – 4.92)
p-value for linear trend 0.030 0.029
Pack-yearsb
Never smoker (0 p-y) 218 23 1.00 15 1.00
Past 117 55 1.67 (0.79 – 3.55) 39 1.15 (0.45 – 2.95)
<20 38 11 1.30 (0.49 – 3.47) 6 0.69 (0.19 – 2.51)
20–49 55 59 2.81 (1.27 – 6.19) 48 2.49 (0.96 – 6.51)
≥ 50 27 54 3.79 (1.60 – 8.95) 52 3.93 (1.40 – 10.99)
p-value for linear trend 0.005 0.007
Age at starting
<15 40 41 1.00 35 1.00
15–17 78 61 1.11 (0.56 – 2.21) 49 1.45 (0.65 – 3.23)
≥ 18 116 70 0.91 (0.47 – 1.74) 56 1.21 (0.57 – 2.58)
Years since quitting
Current Smoker 120 124 1.00 106 1.00
<10 50 26 0.55 (0.29 – 1.06) 20 0.44 (0.20 – 0.96)
≥ 10 67 29 0.65 (0.35 – 1.21) 19 0.49 (0.23 – 1.06)
Type of tobacco
Never 218 23 1.00 15 1.00
Blond 71 31 1.19 (0.50 – 2.82) 24 0.80 (0.28 – 2.30)
Black 150 144 2.50 (1.23 – 5.09) 118 2.05 (0.85 – 4.97)
Inhalation of smoke
Never 218 24 1.00 15 1.00
Partially 164 93 1.50 (0.74 – 3.07) 77 1.32 (0.54 – 3.25)
Totally 72 85 2.88 (1.37 – 6.06) 67 2.53 (1.00 – 6.46)
a Adjusted for sex, age, educational level, province, and alcohol drinking (never, past, 1–24 g/d, 25–74 g/d, ≥ 75 g/d), the energy-adjusted intake of 
fruits and vegetables in tertiles, and energy intake
b Pack-years = the number of packs of 20 cigarettes per day multiplied by the number of years smoking.BMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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Discussion
Our results confirm that alcohol drinking and tobacco
smoking are both strong and independent risk factors for
esophageal cancer in Spain. We found that heavy drinkers
had higher increased risk than heavy smokers, particularly
for the esophageal squamous-cell carcinoma. These
results are consistent with most of the epidemiological
studies carried out in Western countries and some areas of
Asia [4,11,12,22-25]. Other studies have found however,
chewing or tobacco smoking to be a similar or even a
stronger risk factor than alcohol drinking [13,26-28]
although some of these studies did not include subjects
with a high consumption of alcohol [13,26].
Regarding alcohol drinking, we found that the intensity
(i.e. the average daily alcohol intake in grams of pure eth-
anol) was a more relevant predictor of risk than the dura-
tion of the habit. The age at which subjects started
drinking was not associated with risk and the cessation of
drinking was not associated with any beneficial effect even
≥ 5y after cessation. The consequences of drinking cessa-
tion has been studied less frequently than smoking cessa-
tion and results are more controversial, probably because
the number of people who quit drinking is lower than
those who quit smoking. A beneficial effect has been
found in some studies particularly 10 years after giving up
drinking [25,29] although some studies have shown a
rapid decline in risk after cessation of drinking [4,30,31].
On the contrary, other studies have shown either a non
beneficial effect [23] or a higher risk among former drink-
ers [31,32]. In our study we observed a statistically signif-
icant increased risk among former drinkers who stopped
drinking <5y. Unfortunately, we had an insufficient
number of former drinkers to explore the drinking cessa-
tion after 10 years in more detail. Although we considered
as former drinkers those who reported quitting at least
one year before the interview, it is possible that some of
the patients were in fact heavy drinkers quitting the habit
because of their disease; alternatively, it may also be pos-
sible that some heavy drinker cases misreported their
habit, declaring no consumption when in fact they were
still drinking and consequently exhibited a higher risk
than never drinkers.
We were also interested in exploring the effect of the alco-
hol type since the consumption of wine, beer and spirits
is quite common in Spain [33] and thus, it may have a
great interest for public health. Most of the studies have
supported the hypothesis that the amount of alcohol con-
sumed is the determinant of the risk rather than the par-
ticular drink, however, a prospective cohort study in
Denmark showed that a moderate intake of wine, com-
pared to beer and hard liquor, did not increase the risk [5].
Previously, two population-based case-control studies in
the United States did not find an association between
wine drinking and the risk of esophageal cancer [34,35],
and later, two other studies showed data supporting a lack
of effect for wine drinking as well [6,7]. Conversely, in
other studies where wine was by far the most common
alcoholic beverage, wine drinkers showed higher risk than
those of other beverages [23,36]. In our study, the con-
sumption of all types of beverages that include hard liq-
uors was a much stronger risk factor than wine and/or
beer. We observed a statistically significant increased risk
of EC among only beer drinkers but not among only wine
or wine/beer drinkers. When the daily amount by type of
beverage was considered, no increased risks were observed
for a low-moderate wine-beer consumption (1–24 d/
day), and a 2-fold increase risk among drinkers of ≥ 25g/
d although it was not statistically significant. However, we
observed a 5.76-fold increase risk among drinkers of ≥ 25
g/d of all types of beverages (risk for the combined catego-
ries of 25–74 g/d and ≥ 75 g/d of all types of beverages,
table 2). A low-moderate wine-beer consumption of 1–24
g/d did not increase significantly the risk of esophageal
squamous-cell carcinoma either. If the lack of effect of
wine and/or beer is real, there may be some protective
ingredients in wine such as resveratrol [37] and other anti-
oxidants that may cause such a protective effect [38].
It is not clear the exact mechanisms by which alcoholic
beverages induce esophageal cancer risk. An ingredient
common to all beverages is ethanol although it is possible
that other components or contaminants such as N-nitro-
samines and urethane with carcinogenic properties may
increase cancer risk. It has been shown in practically all
the studies that the risks are greatest for drinkers of hard
liquors which is consistent with evidence that the concen-
tration of ethanol plays an important role in alcohol-
related tumours of the upper aero-digestive tract
[13,39,40]. Although ethanol has not been shown as car-
cinogenic in laboratory animals, it may act through its
major metabolite, acetaldehyde, a carcinogen in animal
models [41,42]. Thus, it has been suggested that in addi-
tion to a systemic effect, ethanol can be converted to
acetaldehyde in saliva and exert a promoting effect by
either solubilising tobacco-specific carcinogens or
enhancing their penetration into the esophageal mucosa,
by nutritional deficiencies associated with heavy drinking
or by other mechanisms (e.g., direct toxic or oxidative
effect on the epithelial mucosa) [41,43]. In order to
explain the differential effect of alcoholic beverages it
should be considered that certain compounds such as N-
nitrosamines are found in liquors and to lesser extent in
beer, and urethane, a potential carcinogen in experimen-
tal studies, may be found in liquor but not in beer and
wine. In addition, while most of the antioxidant com-
pounds found in wine and to some extent in beer, are
almost completely lacking in spirits [38].
It has been also suggested that part of the effect observed
for alcohol and/or tobacco smoking could be due to otherBMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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factors or different lifestyles, such as a low fruit and vege-
table intake [10]. However, our data were adjusted for the
intake of fruit and vegetables showing that alcohol and
tobacco were strong risk factors although the risk esti-
mates were much higher when we did not adjust for fruits
and vegetables intake (data not shown). We also observed
that alcohol drinking was a much stronger risk factor for
squamous-cell carcinoma than for the whole control
series. This finding would indirectly support the hypothe-
sis that the effect of alcohol for adenocarcinoma may be
much weaker, if any. In fact, when we estimated the risk
of adenocarcinoma for wine-beer drinkers and all types of
alcohol beverages with respect to never drinkers, we did
not find any increase of risk (OR = 0.83 and OR = 0.97,
respectively); and for former and current drinker vs never
drinkers, we did not find any significant risk either (OR =
1.83 and OR 0.74, respectively). Although some studies
have found slight excesses of adenocarcinoma among
drinkers [34,35,44], most of the previous case-control
studies between alcohol drinking and the risk of oesopha-
geal adenocarcinoma have generally found no association
[6,7,45-47]. Unfortunately, the number of adenocarci-
noma cases in our study was too small (n = 42) to allow
us a separate analysis in great detail. The reasons for the
differential effect of alcohol drinking on oesophageal
squamous cell-carcinoma and adenocarcinoma should be
further examined.
Concerning tobacco smoking, the effect estimates were
lower than the observed for alcohol intake although dose-
response trends were still evident for the amount and the
duration of smoking. Although the effect of tobacco
smoking has been considered by practically all studies on
esophageal cancer only a few have explored the effects by
type of tobacco black/blond. The increased risk of black
tobacco compared to blond tobacco is consistent with
ecological studies showing a relatively high incidence of
cancers of upper aero-digestive tract in southern Europe
and Latin America, where this kind of tobacco is mainly
consumed [48]. Our results are consistent with other stud-
ies carried out in high-risk areas of South America [4,49].
We observed a statistically significant effect for black
tobacco but not for blond tobacco although the lack of
effect for low-to-moderate blond tobacco smoking was
based on a small number of cases (n = 31). It has been
suggested that the higher concentrations of some carcino-
genic compounds such as N-nitrosamines found in smoke
of black tobacco could be a mechanism involved [43].
Unlike our findings for alcohol cessation, we observed a
beneficial effect of cessation of smoking. Similarly to oth-
ers [4,6], we found that the risk of esophageal cancer
declined within a decade of smoking cessation which may
suggest that smoking could act during later stages as a pro-
moter in the development of esophageal cancer, predom-
inantly for the esophageal squamous-cell carcinoma.
In order to explore the joint effects of alcohol and
tobacco, unfortunately we could not perform interaction
tests because of the small numbers. There was evidence
that the effect of both exposures were nearly multiplica-
tive. If we accept a multiplicative effect, we could assume
that the risk of being simultaneously a heavy drinker (≥ 75
g/d) and heavy smoker (>50 p/y) could be as high as 40
times that of abstainers, or even 100 times when referring
to esophageal squamous-cell carcinoma.
As in other case-control studies, this study may present
limitations. The sample size was small, and we could not
explore interaction between tobacco and alcohol in more
detail but the effects of each exposure became evident
even among those non-exposed to the other. Another lim-
itation may relate to the use of hospital controls. It is
known that controls in hospital-based studies may be
heavier smokers and heavier drinkers compared with gen-
eral population; but we used a wide criterion to select con-
trols from diagnosis a priori not related to the main risk
factors of our study. In fact, the prevalence of drinking or
smoking among control subjects was similar to that
observed in the adult general population of the same sex
and age composition of Alicante and Valencia, and thus it
could be considered as representative of that popula-
tion[33]. The presence of other types of bias were mini-
mized by selecting controls from the same hospital as the
cases, using the same interviews and procedures in both
cases and controls to avoid any differential misclassifica-
tion. The strength of the associations, the existence of a
dose-response, the reduction of effect after cessation, the
control for other potential confounder such as education
and the intake of fruits and vegetables, and the consist-
ency with other studies would support that the study
results are real, and that alcohol drinking and tobacco
smoking are likely to be causally related to esophageal
cancer.
Conclusion
In conclusion, this case-control study shows that the risk
of esophagus cancer, and particularly the squamous cell
type, is strongly associated with alcohol drinking. The
consumption of any combination of hard liquors seems
to be harmful whereas a low consumption of only wine
may not. Tobacco smoking is also a strong risk factor,
black more than blond. Smoking cessation was shown a
beneficial effect within ten years whereas drinking cessa-
tion was not. A possible differential effect of alcohol
drinking on oesophageal squamous cell-carcinoma
(harmful) and adenocarcinoma (no effect) should be fur-
ther examined.BMC Cancer 2008, 8:221 http://www.biomedcentral.com/1471-2407/8/221
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